Alterations in Neocortical Neuron Excitability Associated with Fragile X

With a $107,000 grant from FRAXA Research Foundation from 2005-2006, Dr. Charles Cox at the University of Illinois looked for alterations in the intrinsic excitability of individual neurons within the visual neocortex in Fragile X syndrome.

Charles Cox, PhD, at University of Illinois at Urbana-Champaign, FRAXA research grant
$107,000 Grant
Charles Cox, PhD
Principal Investigator
University of Illinois at Urbana-Champaign
2005-2006 FRAXA Research Grant
$107,000 over 2 Years

Alterations in Neocortical Neuron Excitability Associated with Fragile X

by Charles Cox, 9/1/2005

While it is clear that Fragile X syndrome results from a single gene defect, the consequences of this alteration can produce a variety of changes in the nervous system. The circuit activity of neuronal networks is ultimately influenced by the intrinsic excitability of individual neurons, and their synaptic connectivity. Recent studies have indicated robust modifications in the dendritic structures of neurons in the Fragile X conditions, but the functional significance of these changes is unclear. Furthermore, multiple studies in the hippocampus have indicated alterations in synaptic plasticity associated with Fragile X, but less is known regarding alterations in the neocortex.

Our experiments are designed to determine whether there are alterations in the intrinsic excitability of individual neurons within the visual neocortex. We will use modern intracellular recording techniques to determine if there are alterations in intrinsic properties or synaptic transmission within neocortical neurons. In addition, we will investigate alterations in long-term potentiation (LTP) within the neocortex, with an emphasis on metabotropic glutamate receptor mediated plasticity. Differences in these fundamental properties of neurons could greatly impact the cell’s normal function and its ability to communicate with surrounding neurons, potentially providing possible explanations for neural deficits associated with Fragile X syndrome.

Global Leader in Fragile X Research

FRAXA-funded researchers around the world are leading the way towards effective treatments and ultimately a cure.

Explore Current Research Grants
Help Fund the Cure

Global Leader in Fragile X Research

FRAXA-funded researchers around the world are leading the way towards effective treatments and ultimately a cure.

Explore Current Research Grants
Help Fund the Cure